Recent Articles

July 21, 2014 2:45 pm
Cynthia Fox
In two months, the first of many new Parkinson’s disease (PD) patients will receive a fetal cell transplant. The transplant will mark the end of a voluntary moratorium by many Western nations after complications arose a decade ago. This, combined with news that embryonic stem (ES) cell PD therapies may also near prime-time, made Parkinson’s a big topic at the recent International Society for Stem Cell Research (ISSCR) meeting.
July 17, 2014 1:22 pm
Bioscience Technology Staff
Many promising clinical trials were highlighted at the annual meeting of the International Society of Stem Cell Research (ISSCR). One set of trials highlighted were monogenic gene therapy trials and cancer immunotherapy trials. Also discussed were trials for Parkinson’s disease, Multiple Sclerosis, and potential future trials involving cochlear stem cells.
July 15, 2014 2:32 pm
Skip Derra
What we currently know about aging is not highly specific; our cells divide many times throughout our lives and eventually cause organs and our bodies to age, break down and fail. New research, however, suggests that how we age might depend on cellular interactions that we inherit from our ancestors, accumulating throughout many generations.
July 2, 2014 2:55 pm
Cynthia Fox
Just as Nature was setting about retracting two famous Riken CDB papers claiming to make “STAP” stem cells from ordinary cells, another Riken researcher said she might suspend a world-first clinical trial of a competing—legitimate—stem cell technique. But within hours, she modified her views, according to Riken.
July 1, 2014 12:07 pm
Cynthia Fox
At 21, MS had Jennifer Molson “wheelchair bound.” But since her stem cell transplant, she has worked, driven, danced at her own wedding. The story had a room of 1,000 professional stem cell scientists sniffling loudly at the International Society for Stem Cell Research (ISSCR) meeting—said sniffling reaching a crescendo when the quiet, pretty Molson concluded: “I’m living proof stem cells can save lives.”
June 18, 2014 12:59 pm
Cynthia Fox
As Nobel Prize-winning scientist Shinya Yamanaka regaled a New York crowd with advances that may send his Japanese institute to the top of the global stem cell field, investigators in Tokyo said the stem cell division at his sister institute is so wracked with problems it should dismantle—or dramatically revamp.
June 17, 2014 1:57 pm
Neil Canavan
Everyone loves a grand slam: the crack of the bat, the arc of the ball as it sails over the fence, a tip of the batter’s cap, a triumphal trot around as the bases empty out, but really, it’s the lesser efforts that made it all possible—a double, a single, a walk—it’s the incremental gains that win the game. It’s called Small Ball. This year’s ASCO, absent the heavy hitters, was all about the small ball.
June 13, 2014 2:49 pm
Neil Canavan
Federal funding for cancer research has diminished over the last ten years, and the negative impact on research is now apparent. There were no blockbuster revelations, no flashy new kid on the block, no miracle cures at this year’s ASCO. Of the four studies selected for the plenary session (where presentations are often THE important findings of the conference), only one is predicted to have a major impact on patient care.
June 6, 2014 9:00 am
Skip Derra
You are what you eat, but researchers are beginning to realize that what and when you eat is controlled by a myriad of underlying biological triggers acting in concert.                       
June 5, 2014 2:25 pm
Cynthia Fox
The popular “Paleo diet,” oft described as an ancient diet dominated by grasses and modeled after diets from the Paleolithic period, may not quell hunger better than the modern “McDonald’s” diet.               
Subscribe to Bioscience Technology